drugset / Trial / NCT03951649

Acute Headache Treatment in Pregnancy: Occipital Nerve Block vs PO Acetaminophen With Caffeine

NCT03951649 ↗

Phase 4 Completed 62 enrolled University of Alabama at Birmingham
RandomizedParallel-groupOpen-labelTreatment

Summary

This is an open label randomized controlled trial evaluating response to bupivacaine occipital nerve block compared to Tylenol/Caffeine cocktail in treatment of pregnant patients seeking care of headache.

Timeline

Start
2020-02-10
Primary completion
2022-12-31
Completion
2022-12-31

Outcome

Missed primary endpoint

paper The primary outcome, headache improvement to visual rating scale score of 3 or lower, was not significantly different between groups (64.5% vs 51.6%, P =.30). PMID 37769308 ↗

registry analysis (superiority test); Occipital Nerve Block vs Oral Acetaminophen/Caffeine Group; p = 0.30; Chi-squared NCT03951649 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 650 mg Oral
Subject Bupivacaine Other / unclassified 0.5 % Other
Subject Bupivacaine Other / unclassified 5 ml Other
Subject Caffeine Small molecule 100 mg Oral